ARTICLE | Clinical News
Cleveland BioLabs preclinical data
July 9, 2012 7:00 AM UTC
In a mouse model of breast cancer, chronic administration of oral CBL0137 inhibited mammary tumor onset, delayed tumor progression and prolonged survival in a dose-dependent manner. Additionally, CBL0...